These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26778149)

  • 1. Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.
    Sangshetti JN; Kalam Khan FA; Kulkarni AA; Patil RH; Pachpinde AM; Lohar KS; Shinde DB
    Bioorg Med Chem Lett; 2016 Feb; 26(3):829-835. PubMed ID: 26778149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileishmanial potential of fused 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiols: Synthesis, biological evaluations and computational studies.
    Patil SR; Asrondkar A; Patil V; Sangshetti JN; Kalam Khan FA; Damale MG; Patil RH; Bobade AS; Shinde DB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3845-3850. PubMed ID: 28693910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents.
    Taha M; Ismail NH; Imran S; Anouar EH; Selvaraj M; Jamil W; Ali M; Kashif SM; Rahim F; Khan KM; Adenan MI
    Eur J Med Chem; 2017 Jan; 126():1021-1033. PubMed ID: 28012342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antileishmanial activity and docking study of N'-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides.
    Sangshetti JN; Shaikh RI; Khan FA; Patil RH; Marathe SD; Gade WN; Shinde DB
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1605-10. PubMed ID: 24513045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave-assisted synthesis of novel 5-substituted benzylidene amino-2-butyl benzofuran-3-yl-4-methoxyphenyl methanones as antileishmanial and antioxidant agents.
    Patil SR; Bollikonda S; Patil RH; Sangshetti JN; Bobade AS; Asrondkar A; Reddy PP; Shinde DB
    Bioorg Med Chem Lett; 2018 Feb; 28(3):482-487. PubMed ID: 29258770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents.
    Bekhit AA; Saudi MN; Hassan AM; Fahmy SM; Ibrahim TM; Ghareeb D; El-Seidy AM; Al-Qallaf SM; Habib HJ; Bekhit AEA
    Future Med Chem; 2018 Oct; 10(19):2325-2344. PubMed ID: 30215271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.
    Khan FA; Zaheer Z; Sangshetti JN; Patil RH; Farooqui M
    Bioorg Med Chem Lett; 2017 Feb; 27(3):567-573. PubMed ID: 28003139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights about resveratrol analogs against trypanothione reductase of
    da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ
    J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase.
    da Silva ER; Brogi S; Grillo A; Campiani G; Gemma S; Vieira PC; Maquiaveli CDC
    Chem Biol Drug Des; 2019 Feb; 93(2):139-146. PubMed ID: 30216691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
    Alam MS; Lee DU
    Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Pharmacophoric Approach in the Design and Synthesis of Coumarin Linked Pyrazolinyl as Urease Inhibitors, Kinetic Mechanism and Molecular Docking.
    Saeed A; Mahesar PA; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Chem Biodivers; 2017 Aug; 14(8):. PubMed ID: 28574649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
    Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis.
    De Luca L; Ferro S; Buemi MR; Monforte AM; Gitto R; Schirmeister T; Maes L; Rescifina A; Micale N
    Chem Biol Drug Des; 2018 Sep; 92(3):1585-1596. PubMed ID: 29729080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, in vitro evaluation, molecular docking and ADME properties studies of hybrid bis-coumarin with thiadiazole as a new inhibitor of Urease.
    Alomari M; Taha M; Imran S; Jamil W; Selvaraj M; Uddin N; Rahim F
    Bioorg Chem; 2019 Nov; 92():103235. PubMed ID: 31494327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spiro-Acridine Compound as a Pteridine Reductase 1 Inhibitor: in silico Target Fishing and in vitro Studies.
    de Oliveira Viana J; Sena Mendes M; Santos Castilho M; Olímpio de Moura R; Guimarães Barbosa E
    ChemMedChem; 2024 Jun; 19(11):e202300545. PubMed ID: 38445815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents.
    Zaheer Z; Khan FA; Sangshetti JN; Patil RH
    EXCLI J; 2015; 14():935-47. PubMed ID: 26839526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
    Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
    Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections.
    Linciano P; Pozzi C; Iacono LD; di Pisa F; Landi G; Bonucci A; Gul S; Kuzikov M; Ellinger B; Witt G; Santarem N; Baptista C; Franco C; Moraes CB; Müller W; Wittig U; Luciani R; Sesenna A; Quotadamo A; Ferrari S; Pöhner I; Cordeiro-da-Silva A; Mangani S; Costantino L; Costi MP
    J Med Chem; 2019 Apr; 62(8):3989-4012. PubMed ID: 30908048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New thiophene-acridine compounds: Synthesis, antileishmanial activity, DNA binding, chemometric, and molecular docking studies.
    de Lima Serafim V; Félix MB; Frade Silva DK; Rodrigues KADF; Andrade PN; de Almeida SMV; de Albuquerque Dos Santos S; de Oliveira JF; de Lima MDCA; Mendonça-Junior FJB; Scotti MT; de Oliveira MR; de Moura RO
    Chem Biol Drug Des; 2018 Jun; 91(6):1141-1155. PubMed ID: 29415325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.